FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Bausch & Lomb Muro 128 Recall

Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tu…

Bausch & Lomb, Inc. · Tampa, FL

Risk level
Class II
Reported by FDA
Jul 2, 2014
Recall ID
D-1410-2014
Check your lot numberHow we source this data

Summary

Bausch & Lomb recalled Muro 128 starting Apr 10, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1410-2014 on Jul 2, 2014. Reason: Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye. Status: Terminated.

Why it was recalled

Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.

Product description

Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton, professional sample, NDC 24208-385-01, UPC 3 24208-385-01 2; b) 1/8 oz. (3.5 g) tube per carton, NDC 24208-385-55, UPC 3 24208-385-55 5; and c) 1/4 oz. (7 g) Twin Pack, Two 1/8 oz. (3.5 g) tubes per carton, NDC 24208-385-56, UPC 3 24208-385-56 3; Bausch & Lomb Incorporated, Tampa, FL 33637.

Lot numbers, UPCs & expiration codes

Lot #: a) 179271, Exp 08/14; b) and c) 146791, 146932, Exp 06/14; 151221, 151922, Exp 09/14; 159102, Exp 02/15; 160912, Exp 03/15; 162422, Exp 04/15; 163641, 05/15; 166592, Exp 07/15; 169273, Exp 09/15; 170482, Exp 10/15; 174882, Exp 12/15; 176932, Exp 01/16; 179272, Exp 02/16; 182772, Exp 05/16; 186722, Exp 07/16; 190182, Exp 09/16; and 191631, Exp 10/16

Where it was sold

Nationwide, Puerto Rico, Canada, and Hong Kong.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1410-2014
Classification
Class II
Status
Terminated
Recall initiated
Apr 10, 2014
FDA report date
Jul 2, 2014
Quantity
a) 4,165 tubes; b) and c) 844,879 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Bausch & Lomb, Inc.

Original FDA data

Every field from FDA enforcement report D-1410-2014, exactly as published.

Show all FDA fields
City
Tampa
State
FL
Status
Terminated
Country
United States
Event ID
68348
Address
8500 Hidden River Pkwy
Code information
Lot #: a) 179271, Exp 08/14; b) and c) 146791, 146932, Exp 06/14; 151221, 151922, Exp 09/14; 159102, Exp 02/15; 160912, Exp 03/15; 162422, Exp 04/15; 163641, 05/15; 166592, Exp 07/15; 169273, Exp 09/15; 170482, Exp 10/15; 174882, Exp 12/15; 176932, Exp 01/16; 179272, Exp 02/16; 182772, Exp 05/16; 186722, Exp 07/16; 190182, Exp 09/16; and 191631, Exp 10/16
Postal code
33637-1014
Report date
Jul 2, 2014
Product type
Drugs
Recall number
D-1410-2014
Classification
Class II
Recalling firm
Bausch & Lomb, Inc.
Product quantity
a) 4,165 tubes; b) and c) 844,879 tubes
Termination date
Apr 14, 2017
Reason for recall
Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton, professional sample, NDC 24208-385-01, UPC 3 24208-385-01 2; b) 1/8 oz. (3.5 g) tube per carton, NDC 24208-385-55, UPC 3 24208-385-55 5; and c) 1/4 oz. (7 g) Twin Pack, Two 1/8 oz. (3.5 g) tubes per carton, NDC 24208-385-56, UPC 3 24208-385-56 3; Bausch & Lomb Incorporated, Tampa, FL 33637.
Distribution pattern
Nationwide, Puerto Rico, Canada, and Hong Kong.
Recall initiation date
Apr 10, 2014
Initial firm notification
Letter
Center classification date
Jun 25, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1410-2014, published Jul 2, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls